BioNTech SE (BNTX)
87.51
+1.65
(+1.92%)
USD |
NASDAQ |
Nov 06, 16:00
87.57
+0.06
(+0.07%)
After-Hours: 20:00
BioNTech Free Cash Flow : -563.78M for Sept. 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2026 | -563.78M |
| June 30, 2026 | 424.34M |
| March 31, 2026 | 1.177B |
| December 31, 2025 | 289.80M |
| September 30, 2025 | -588.89M |
| June 30, 2025 | -2.152B |
| March 31, 2025 | -1.245B |
| December 31, 2024 | -266.00M |
| September 30, 2024 | 1.478B |
| June 30, 2024 | 2.990B |
| March 31, 2024 | 5.782B |
| December 31, 2023 | 5.500B |
| Date | Value |
|---|---|
| September 30, 2023 | 4.800B |
| June 30, 2023 | 8.828B |
| March 31, 2023 | 8.531B |
| December 31, 2022 | 13.78B |
| September 30, 2022 | 13.03B |
| June 30, 2022 | 10.02B |
| March 31, 2022 | 5.756B |
| December 31, 2021 | 870.50M |
| September 30, 2021 | 1.415B |
| June 30, 2021 | -575.28M |
| March 31, 2021 | -453.87M |
| December 31, 2020 | -113.26M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Biodexa Pharmaceuticals Plc | -10.63M |
| Moderna, Inc. | -1.244B |
| Mereo BioPharma Group Plc | -25.58M |
| NuCana Plc | -6.612M |
| Immatics NV | -246.23M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -148.25M |
| Cash from Investing (Quarterly) | 922.53M |
| Cash from Financing (Quarterly) | -269.92M |
| Free Cash Flow Per Share (Quarterly) | -0.8062 |
| Free Cash Flow to Equity (Quarterly) | -418.70M |
| Free Cash Flow to Firm (Quarterly) | -200.42M |
| Free Cash Flow Yield | -2.57% |